A phase 1 study to assess BDTX-1535, an oral EGFR inhibitor, in patients with glioblastoma or non-small cell lung cancer

temozolomide - Generic mfg.

BDTX-1535 - Black Diamond Therap

https://www.abstractsonline.com/pp8/#!/10828/presentation/10469

Melissa Johnson; Jason Henry; Alex Spira; James Battiste; Iyad Alnahhas; Manmeet Ahluwalia; Minal Barve; Jeffrey Edenfield; DoHyun Nam; Sudharshan Eathiraj; Julio Hajdenberg; Sergey Yurasov; Helena Yu; Patrick Wen

Mar 14, 2023